Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore,
general physicians should be familiar with the diagnosis and management of affected …

Glaucoma is a progressive optic neuropathy that is the second leading cause of preventable
blindness worldwide, after cataract formation. A rise in the intraocular pressure (IOP) is …

PURPOSE To compare effectiveness and safety of the gel stent to trabeculectomy in open-
angle glaucoma (OAG). DESIGN Prospective, randomized, multicenter, noninferiority study …

Prostaglandin (PG) receptors represent important druggable targets due to the many diverse
actions of PGs in the body. From an ocular perspective, the discovery, development, and …

Glaucoma is a chronic, debilitating disease and a leading cause of global blindness.
Despite treatment efforts, 10% of patients demonstrate loss of vision. In the US,> 80% of …

Purpose The efficacy and safety of the trabecular micro-bypass stents (iStent and iStent
inject) have been well documented in various open-angle glaucoma subtypes. However …

Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment
techniques are rapidly expanding the availability of therapeutic options for glaucoma. These …

Topical glaucoma medications are effective and safe, but they have numerous well-
documented limitations that diminish their long-term utility and sustainability. These …

Objectives: Describe the technique of minimally invasive glaucoma surgery. Review the
indications of minimally invasive glaucoma surgery. Summarize the contraindications of …

Glaucoma is a serious complication after corneal transplantation and itself a common cause
for graft failure and leading cause of vision loss post-keratoplasty due to corneal endothelial …